Why Assigning Patents To Native American Tribes To Avoid Inter Partes Review Is Bad Medicine
Here are three big reasons why, according to IP columnist Tom Kulik.
3 Questions For IBM’s Chief Patent Counsel
Columnist Gaston Kroub interviews Manny Schecter, a leading voice in the IP community.
Managing Partners are Navigating the AI Inflection Point.
New executive research from Ari Kaplan explores how law firm leaders are responding to changing client expectations, evolving economics, talent transformation, and AI governance.
A New Patent Loophole? Paying Off A Native American Tribe To Exploit Its Sovereign Immunity
If this tactic is allowed, it will be a big win for Big Pharma -- and a big loss for patients and consumers.
Supreme Court, Patent Saviors?
The Supreme Court just agreed to decide a profoundly important question in patent law right now.